Perbak Capital Partners’s Progyny PGNY Stock Holding History

Perbak Capital Partners’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,173	Closed	-$272K	–	319
2025 Q1	$272K	Buy	+12,173	New	+$262K	0.2%	144

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Perbak Capital Partners's PGNY Position: Q2 2025 in Review

Perbak Capital Partners sold out of Progyny (PGNY) in Q2 2025, closing a stake of 12,173 shares — an estimated $272K sold.

Perbak Capital Partners first reported a position in PGNY in Q1 2025 and held it in 1 quarter. The position peaked at $272K in Q1 2025. 302 funds tracked by Wall St. Rank hold PGNY as of Q2 2025.

Perbak Capital Partners reported no remaining Progyny position as of Q2 2025 after selling out during the quarter.
Perbak Capital Partners sold 12,173 Progyny shares in Q2 2025, an estimated $272K.
Perbak Capital Partners first reported a position in Progyny in Q1 2025 and held it in 1 quarter.
Perbak Capital Partners's Progyny position peaked at $272K in Q1 2025.
302 funds tracked by Wall St. Rank held Progyny as of Q2 2025.

Based on Perbak Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.